# Amy S. Paller

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/amy-s-paller/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50,006 |
| Field | Dermatology and Skin Diseases |
| h-index | 110 |
| i10-index | 542 |
| Last Known Institution | Northwestern University |
| OpenAlex ID | https://openalex.org/A5020095047 |
| ORCID iD | https://orcid.org/0000-0001-6187-6549 |
| Works | 1,233 |

## Researcher papers

Showing 12 of 21.

- [Guidelines of care for the management of atopic dermatitis](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-atopic-dermatitis-2/)
- [Guidelines of care for the management of atopic dermatitis](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-atopic-dermatitis-3/)
- [Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis/)
- [Guidelines of care for the management of atopic dermatitis](https://scholariq.org/papers/guidelines-of-care-for-the-management-of-atopic-dermatitis/)
- [Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorèze 2009](https://scholariq.org/papers/revised-nomenclature-and-classification-of-inherited-ichthyoses-results-of-the/)
- [Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults](https://scholariq.org/papers/efficacy-and-safety-of-crisaborole-ointment-a-novel-nonsteroidal/)
- [Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials](https://scholariq.org/papers/once-daily-upadacitinib-versus-placebo-in-adolescents-and-adults-with-moderate/)
- [The microbiome in patients with atopic dermatitis](https://scholariq.org/papers/the-microbiome-in-patients-with-atopic-dermatitis/)
- [Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis](https://scholariq.org/papers/efficacy-and-safety-of-dupilumab-in-adolescents-with-uncontrolled-moderate-to/)
- [Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis-2/)
- [The atopic march and atopic multimorbidity: Many trajectories, many pathways](https://scholariq.org/papers/the-atopic-march-and-atopic-multimorbidity-many-trajectories-many-pathways/)
- [Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-dupilumab-with-concomitant-topical-corticosteroids-in/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Skin and Cellular Biology Research](https://scholariq.org/topics/skin-and-cellular-biology-research/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)

## Researcher university

- [Northwestern University](https://scholariq.org/institutions/northwestern-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.